Includes all of these sessions from the conference: (all times are Eastern Time)
| THURSDAY, MARCH 1, 2018 |
|
|
Masters of Pediatric Dermatology Symposium |
Session Director: Lawrence A. Schachner, MD |
| 8:30 am - 8:35 am |
Introduction |
Lawrence A. Schachner, MD |
| 8:35 am - 9:10 am |
Emerging Infections in Pediatric Skin |
Lawrence F. Eichenfield, MD |
| 9:10 am - 9:45 am |
Psoriasis: Therapeutic Update in Children |
Lawrence A. Schachner, MD |
| 9:45 am - 10:20 am |
Treatment of Warts and Molluscum in Children |
Anna Nichols, MD, PhD |
| 10:50 am - 11:25 am |
Acne from Infants to Teenagers: A Review of Treatments Old and New |
Jonette E. Keri, MD, PhD |
| 11:25 am - 12:00 pm |
An Update on Diagnosis and Treatment of Vascular Lesions in Infants and Children |
Mercedes E. Gonzalez, MD |
| 1:15 pm - 1:50 pm |
Top Stories in Childhood Hair Disorders |
Antonella Tosti, MD |
| 1:50 pm - 2:25 pm |
Weird and Worrisome Pediatric Rashes |
Lawrence F. Eichenfield, MD |
| 2:25 pm - 3:30 pm |
Pediatric Atopic Dermatitis Symposium |
Lawrence F. Eichenfield, MD and Lawrence A. Schachner, MD |
|
Diagnosis, Management and Treatment of Skin Cancer |
Session Director: Darrell S. Rigel, MD, MS |
| 3:30 pm- 3:45 pm |
Epidemiology of Melanoma and Non-Melanoma Skin Cancer (NMSC) |
Darrell S. Rigel, MD, MS |
| 3:45 pm - 4:00 pm |
Advances in the Diagnosis and Prognosis of Melanoma and NMSC |
Clay Cockerell, MD |
| 4:00 pm - 4:15 pm |
New AAD NMSC Guidelines |
Suzanne Olbricht, MD |
| 4:15 pm - 4:30 pm |
Surgical and Non-Surgical Treatments for Skin Cancer |
David J. Goldberg, MD, JD |
| 4:30 pm - 4:45 pm |
Treatment of AK |
Neal Bhatia, MD |
| 4:45 pm - 5:00 pm |
Panel Discussion: What to Do with Dysplastic Nevi: A Discussion |
Moderator: Darrell S. Rigel, MD, MS; Panelists: Clay Cockerell, MD and David J. Goldberg, MD, JD, Suzanne Olbrich, MD. |
|
Special Session: Anti-Aging Medicine for the Dermatologist |
Session Director: Andrew Heyman, MD |
| 5:00 pm - 5:30 pm |
Introduction to Bioidentical Hormone Replacement: What the Dermatologist Needs to Know |
Andrew Heyman, MD |
| 5:30 pm - 6:15 pm |
Compounding for Dermatology |
Sahar Swidan, PharmD |
| FRIDAY, MARCH 2, 2018 |
|
|
Innovations in Clinical Therapeutics I |
Session Director: David E. Cohen, MD, MPH |
| 7:30 am - 7:45 am |
Pharmaceutical Breakthroughs and Clinical Trials Update |
Leon Kircik, MD |
| 7:45 am - 8:00 am |
PDT for the Treatment of Actinic Keratosis |
Brian Berman, MD, PhD |
| 8:00 am - 8:15 am |
Rosacea Management and Therapeutic Options |
James Q. Del Rosso, DO |
| 8:15 am - 8:30 am |
Onychomycosis and Other Disorders of the Nails |
Antonella Tosti, MD |
| 8:30 am - 8:45 am |
Photodynamic Therapy: Practical Uses to Treat a Variety of Dermatologic Conditions |
Neal Bhatia, MD |
| 8:45 am - 9:00 am |
Treatment Options for Melasma |
Seemal Desai, MD |
|
Acne Symposium |
Session Director: James Q. Del Rosso, DO |
| 9:45 am - 10:00 am |
Therapeutic Advancements and the Future of Acne Therapy |
James Q. Del Rosso, DO |
| 10:00 am - 10:15am |
Acne Diagnosis and Treatment Across the Patient Spectrum |
Diane S. Berson, MD |
| 10:15 am - 10:30 am |
Light and Laser Devices for Acne |
David J. Goldberg, MD, JD |
|
Mini Practice Management Symposium |
Session Director: Mark D. Kaufmann, MD |
| 10:30 am - 10:45 am |
American Academy of Dermatology Update |
Suzanne Olbricht, MD, President of AAD |
| 10:45 am - 11:00 am |
Essential Office Updates: New Codes for 2018, MACRA, etc. |
Mark D. Kaufmann, MD |
| 11:00 am - 11:15 am |
Emerging Practice Models |
Mark S. Nestor, MD, PhD |
|
Futures Symposium Innovations in Clinical and Aesthetic Dermatology |
Session Director: Brian Berman, MD, PhD |
| 11:15 am - 11:25 am |
What’s in the Future for the Medicine Cabinet |
James Q. Del Rosso, DO |
| 11:25 am - 11:35 am |
Itch: What’s New |
Brian Berman, MD, PhD |
| 11:35 am - 11:45 am |
Combating Extrinsic Aging with Polypodium Leucotomos Extract |
Henry Lim, MD |
| 11:45 am - 11:55 am |
Innovations: Seborrheic Keratosis to Warts |
Brian Berman, MD, PhD |
| 11:55 am - 12:05 pm |
Genomic Prognostic Testing in Melanoma |
Darrell Rigel, MD |
| 12:05 pm - 12:15 pm |
Treatment and Prevention of Scars |
Michael H. Gold, MD |
| 12:15 pm - 12:25 pm |
New Molecules for Fibrosis and Scarring |
Ryan Hartwell, PhD |
| 12:25 pm - 12:35 pm |
New Topical Delivery Systems |
Mark S. Nestor, MD, PhD |
| 12:35 pm - 12:45 pm |
Low Level Laser Therapy |
Mark S. Nestor, MD, PhD |
| 12:45 pm - 1:00 pm |
503b: New Pharmaceutical Pathways? |
Gus Bassani, PharmD |
|
Innovations in Clinical Therapeutics II: Psoriasis |
Session Director: Mark G. Lebwohl, MD |
| 2:00 pm - 2:20 pm |
Innovations in Pediatric Psoriasis |
Lawrence A. Schachner, MD |
| 2:20 pm - 2:40 pm |
Therapeutic Advances in Psoriasis Topicals to Biologics |
Mark G. Lebwohl, MD |
| 2:40 pm - 2:55 pm |
Difficult to Treat Areas in Psoriasis Patients including the Nails and Scalp |
Leon Kircik, MD |
| 2:55 pm - 3:15 pm |
Challenges in Managing Psoriasis Patients |
David M. Pariser, MD |
| 3:15 pm - 3:30 pm |
Psoriasis Case Presentations |
Moderator: Brad P. Glick, DO, MPH, Panelists: Mark G. Lebwohl, MD, David M. Pariser, MD, Leon Kircik, MD, Lawrence A. Schachner, MD |
|
Atopic Dermatitis Symposium: An Overview of AD Pathogensis and Treatment Options: New and Emerging |
Session Director: Leon Kircik, MD |
| 4:00 pm - 4:15 pm |
Pathogeneiss and Treatment Targets |
James Q. Del Rosso, DO |
| 4:30 pm - 4:45 pm |
Atopic Dermatitis: Most Recent Developments and Emerging Therapeutic Options |
Leon Kircik, MD |
|
Special Symposium: The Science of Topical Therapy, RX, OTC and Cosmeceuticals |
Session Director: Diane S. Berson, MD |
| 4:45 pm - 4:55 pm |
New Options for Skin Moisturization |
Michael H. Gold, MD |
| 4:55 pm - 5:10 pm |
Skincare Advice for the Aging Patient |
Doris J. Day, MD |
| 5:10 pm - 5:20 pm |
Stem Cells and Regenerative Medicine for Skin and Hair |
Gabriel Nistor, MD |
| 5:20 pm - 5:35 pm |
Cosmeceuticals with Actives and Growth Factors |
Michael H. Gold, MD |
| 5:50 pm - 6:05 pm |
All About Hair: Growth and Restoration Treatments: PRP, Lasers, Growth Factors and Topical Drugs |
Glynis R. Ablon, MD |
| 6:05 pm - 6:15 pm |
Private Label Office Dispensing |
Mark S. Nestor, MD, PhD |
| 6:15 pm - 6:30 pm |
Panel Discussion: What I Use: My Favorite Cosmeceuticals and Supplements |
Moderator: Glynis Ablon, MD. Panelists: Diane S. Berson, MD, Doris J. Day, MD, Michael H. Gold, MD |
| SATURDAY, MARCH 3, 2018 |
|
|
IMCAS Session: Global Aesthetics |
Session Director: Benjamin Ascher, MD |
| 7:30 am - 7:50 am |
Aesthetics: Is It An “Art in Medicine?” |
Frank Rosengaus, MD |
| 7:50 am - 8:10 am |
Non-invasive Rejuvenation: Pearls from Across the World |
Benjamin Ascher, MD |
| 8:10 am - 8:30 am |
Global Innovations: What’s Next for the US |
Michael H. Gold, MD |
| |
Aesthetic Innovations |
Session Director: Glynis R. Ablon, MD |
| 8:30 am - 8:45 am |
Let’s Be Real: Ethical and Valuable Marketing |
Steven Dayan, MD |
| 8:45 am - 9:00 am |
Aesthetic Innovations |
Neil Sadick, MD |
| 9:00 am - 9:15 am |
Injectable Radiofrequency |
Z. Paul Lorenc, MD |
| 9:15 am - 9:45 am |
Management of Surgical Wounds and Scars Roundtable Discussion |
Panelists: Joel L. Cohen, MD, Michael H. Gold, MD, David J. Goldberg, MD, JD, Z. Paul Lorenc, MD |
|
Combining Surgical and Non-Surgical Techniques |
Session Director: Z. Paul Lorenc, MD |
| 5:15 pm - 5:35 pm |
Non-Surgical Facelift: Fact or Fiction |
Z. Paul Lorenc, MD |
| 5:35 pm - 5:55 pm |
Combination Therapy of Surgical vs. Non-Surgical Techniques |
Julius Few, MD |
| 5:55 pm - 6:10 pm |
Myth Busting: Non-Surgical vs. Surgical |
Steven Dayan, MD |
| 6:10 pm - 6:30 pm |
Panel Discussion: Combining Surgical and Non-Surgical Approaches from the Dermatologists’ and Plastic Surgeons’ Perspective |
Moderator: Z. Paul Lorenc, MD. Panelists: Julius Few, MD, David Goldberg, MD, JD, Michael Gold, MD, and Jason Pozner, MD |
| SUNDAY, MARCH 4, 2018 |
|
|
Clinical Innovations in Literature and Practice |
Session Director: Theodore Rosen, MD |
| 7:30 am - 7:45 am |
Update on Topical Treatment of Actinic Keratosis |
Brian Berman, MD, PhD |
| 7:45 am - 8:00 am |
What’s New in Clinical Dermatology |
Theodore Rosen, MD |
| 8:00 am - 8:15 am |
Managing Patients with Skin Pigment Disorders |
Henry Lim, MD |
| 8:15 am - 8:30 am |
Non-Melanoma Skin Cancer: Update on Diagnosis and Treatment Protocols |
Darrell S. Rigel, MD, MS |
| 8:30 am - 8:45 am |
What the Dermatologist Needs to Know about Wound Healing |
Robert Kirsner, MD |
| 8:45 am - 9:00 am |
Infectious Disease Update |
Kenneth Tomecki, MD |
| 9:00 am - 9:15 am |
Innovations in the Treatment of Scars |
Jill Waibel, MD |
|
Aesthetic Innovations in Literature and Practice |
Session Director: Susan H. Weinkle |
| 9:15 am - 9:30 am |
Combination in Aesthetics |
Susan H. Weinkle, MD |
| 9:30 am - 9:45 am |
Aesthetic Anatomy |
Stephen H. Mandy, MD |
| 9:45 am - 10:00am |
The Midface Paradigm |
Frank Rosengaus, MD |
| 10:00 am - 10:15 am |
What Men Want in Corrective Aesthetics |
Doris J. Day, MD |
| 10:15 am - 10:30 am |
Aesthetic Tips |
Glynis R. Ablon, MD |
| 10:30 am - 10:45 am |
Aesthetic Innovations |
Gary D. Monheit, MD |
|
Ask the Experts: Complications Roundtable Discussion |
Session Director: David J. Goldberg, MD, JD |
| 11:00 AM - 11:30 AM |
Surgical and Scar Complications |
David J. Goldberg, MD, JD |
| 11:00 AM - 11:30 AM |
Laser Complications |
Michael H. Gold, MD |
| 11:00 AM - 11:30 AM |
Filler Complications |
Gary D. Monheit, MD |
|
Innovations to Add into Your Practice |
Session Director: Michael H. Gold, MD |
| 11:30 am - 11:45 am |
New Strategies for Body Contouring |
Z. Paul Lorenc, MD |
| 11:45 am - 12:00 pm |
Off Face Uses for Fillers |
Neil S. Sadick, MD |
| 12:00 pm - 12:15 pm |
Picosecond Laser for Tattoos, Scarring and Pigmentation |
Bruce E. Katz, MD |
| 12:15 pm - 12:30 pm |
Female Rejuvenation |
Jason Pozner, MD |
| 12:30 pm - 12:45 pm |
Fat Grafting and PRP for the Face |
Benjamin Ascher, MD |
Accreditation Information:
This activity is jointly provided by Global Education Group and South Beach Symposium.
Activity Dates
Live streaming: March 1-4, 2018
Enduring: March 5, 2018 - March 5, 2019
Target Audience
The educational design of this activity addresses the needs of Nurses, Physician Assistants, Physicians involved in the treatment of patients with dermatology concerns.
Statement of Need/Program Overview
The South Beach Symposium is a four-day educational event delivering content on the newest therapies, technologies, procedures, and practice guidelines for physicians and practitioners in the field of clinical and aesthetic dermatology. The meeting is being live streamed and offering CME/CE to participants that are not able to attend the live meeting.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe individualized treatment regimens for patients with acne based on evidence-based guidelines
- Identify recent advances in the treatment of actinic keratosis that have high levels of patients’ satisfaction, decreased treatment duration, and fewer side-effects
- Compare the efficacy and safety of agents, devices, and techniques currently available in aesthetic dermatology
- Discuss individualized treatment plans for pediatric and adult patients with moderate-to-severe AD based on current guideline recommendations for AD, the safety and efficacy of new and emerging treatment options, comorbidities, and patient quality of life
- Identify strategies to improve adherence to AD treatment strategies and assess the effects of treatment on patient QOL
- Compare evidence-based treatment regimens for chronic idiopathic urticaria
- Evaluate current and emerging malignant melanoma therapies according to mechanism of action, clinical safety efficacy, and recommended usage
- Describe the mechanisms of action and efficacy data on new and emerging treatments for onychomycosis
- Review appropriate therapies for psoriasis in children based on disease severity and available evidence
- Identify recent advances in pediatric atopic dermatitis knowledge and treatment
- Compare appropriate therapies for treatment of acne in children from infants to teenagers, based on recent guidelines and available evidence
- Discuss recent updates in pediatric dermatology including research, advances and therapies
- Evaluate treatment strategies for moderate-to-severe psoriasis based on an understanding of psoriasis as a systemic immune-mediated disease
- List appropriate treatment strategies for patients with rosacea based on individualized patient care
- Explain individualized treatment regimens for patients with wounds, taking into consideration evidence-based guidelines, wound severity and type, the efficacy of combination therapies, patient age, and patient skin type
Program Agenda
The agenda being offered for the live streaming can be found above.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and The South Beach Symposium. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 24.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 25.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Instructions to Receive Credit
An email will be sent following the conclusion of this activity and it will include the online evaluation form and post test. Both the online evaluation and post test are required to receive continuing credit.
Fee Information& Refund/Cancellation Policy
There is a fee for this educational activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter |
Reported Financial Relationship |
Glynis R. Ablon, MD, FAAD |
Nothing to Disclose |
Shino Bay Aguilera, DO |
Consultant: Allergan, Galderma, Cynosure, Skinceuticals; Grant/Research Support: Merz, Solta; Speaker's Bureau: Allergan, Galderma, Cynosure, Merz, Skinceuticals; Stock Shareholder: Solta |
Benjamin Ascher, MD |
Nothing to Disclose |
Laura Auerbach, PA-C |
Nothing to Disclose |
Judith Avinoa, PA-C |
Nothing to Disclose |
Gus Bassani, PharmD |
Stock Shareholder: PCCA, Eagle Analytical, Cynova Labs |
Brian Berman, MD, PhD |
Consultant: LEO, Sensus, DUSA/SUN, Dermira, Novartis, Onset, Galderma, Ferndale, Berg, Valeant, Biofrontera, Bayer, Clark, Medimetrix, Pulse, Miragen, Realm, Sirnaomics, Castle, Novan, Celumigen, Aiviva, Exeltis; Grant/Research Support: LEO, Exeltis, Biofrontera; Speaker's Bureau: EO, Halscion, Sensus, DUSA,, Novartis, Galderma, Genentech, Ferndale, Biofrontera, Exeltis; Stock Shareholder: Dermira, Berg, TopMD, Celumigen |
Diane S. Berson, MD |
Consultant: Galderma, Valeant, Sunbelt, D&G Sienna, La Roche, Aetoris, Allergan |
Neal Bhatia, MD |
Consultant: Actavis, Allergan, Anacor, Aqua, Bayer, Biofrontera, BiopharmX, Dermira, Dusa, Exeltis, Ferndale, Foamix, Galderma, Intraderm, ISDIN, LaRoche-Posay, Leo, Novan, Novartis, PharmaDerm, Promius, Regeneron, Sanofi, SunPharma, and Valeant; Grant/Research Support: Actavis, Allergan, Anacor, Aqua, Bayer, Biofrontera, BiopharmX, Dermira, Dusa, Exeltis, Ferndale, Foamix, Galderma, Intraderm, ISDIN, LaRoche-Posay, Leo, Novan, Novartis, PharmaDerm, Promius, Regeneron, Sanofi, SunPharma, and Valeant |
Kelly Byard, PA-C |
Nothing to Disclose |
Clay Cockerell, MD |
Nothing to Disclose |
Armand B. Cognetta, Jr., MD |
Stock Shareholder: Sensus Healthcare |
David E. Cohen, MD, MPH |
Consultant: Ferndale, Medimetriks, FIDE; Stock Shareholder: Demira, Medimetricks |
Joel L. Cohen, MD |
Allergan: Consultant, Honoraria; Merz: Clinical Investigator, Consultant/Honoraria; Galderma: Consultant/Honoraria; LEO: Clinical Investigator; Sciton: Consultant/Honoraria; CROMA: Clinical Investigator; ALMA: Clinical Investigator; Lutronic: Consultant; Neothetics: Clinical Investigator; Revance: Clinical Investigator; Brickell Biotech: Clinical Investigator |
Doris J. Day, MD |
Honoraria: Allergan, Merz, Galderma, P&G, Lumenis, Alastin, SkinFix; Speaker's Bureau: Galderma, Merz |
Steven Dayan, MD |
Consultant, Grant/Research Support, and Honoraria: Allergan, Galderma, Merz |
James Q. Del Rosso, DO |
Consultant: Aclaris, Allergan, Athenex, Bayer, Cutanea, Dermira, Galderma, Genentech, LeoPharma, Menlo, Novan, Ortho, Pfizer, Promius, Regeneron, SunPharma;
Grant/Research Support: Aclaris, Allergan, Athenex, Bayer, Celgene, Cutanea, Dermira, Galderma, Genentech, Leo Pharma, Menlo, Novan, Ortho, Promius, Regeneron, SunPharma;
Honoraria & Speaker's Bureau: Aclaris, Allergan, Bayer, Celgene, Galderma, Genentech, LeoPharma, Novartis, Ortho, Pfizer, Promius, Regeneron, SunPharma;
Other: Pharmaceutical Rep (Novartis) Respiratory Division (employee) |
Seemal R. Desai, MD |
Consultant: AbbVie, Pfizer, Menlo, Allergan; Grant/Research Support: Symbio, Watson, Menlo, perrigo; Speaker's Bureau: AbbVie, Pfizer, Galderma; FDA PCAC Member |
Lawrence F. Eichenfield, MD |
Consultant/Honoraria: Allergan, Anacor/Pfizer, Cutanea, Dr Reddy's, DS Biopharma, Galderma Labs, Genetech, Leo Pharma, Lilly, Medimetriks, Ralaxar, Regeneron/Sanofi; Investigator: Galderma Labs, Leo Pharma, Regeneron/Sanofi; Consultant/Equity-Options: TopMD; Consultant, Advisory Board, Speaker/Honoraria |
Chad Erickson |
Nothing to Disclose |
Julius W. Few, MD |
Consultant & Honoraria: Sinclair Pharma, Venus Concept, Zeltiq Aesthetics |
Louis R. Frisina |
Nothing to Disclose |
Brad Glick, DO |
Consultant, Honoraria, and Speakers Bureau: Lilly, AbbVie, Janssen, LEO, Novartis, Celgene; Stock Shareholder: TopMD |
Michael H. Gold, MD |
Consultant & Advisory Boards: Aerolase, Allergan, Alma Lasers, Almirall, Anacor Pharmaceuticals, Aquavit, Bayer Health Care, Celgene, Clarisonic, SkinCeuticals, L'Oreal, Croma, DefanAge, DUSA Pharmaceuticals/Sun Pharma, EndyMed, Erchonia, Exeltis, Galderma, Intraderm, Invasix, Johnson & Johnson, Lumenis, Merz, Neothetics, Novartis, Pierre Fabre, Pollenium, Promius, Sente, Sinclair Pharma, Smith & Nephew, Syneron-Candela, Suneva, Thermi Aesthetics, Valeant, Viviscal, Zimmer |
David J. Goldberg, MD, JD |
Consultant: Sensus, Amirall, RSI, WonTech, Strat Pharma; Grant/Research Support: Cutera, Cynosure, Stratpharma, Galderma, Merz, Allergan; Honoraria: Cutera, Sensus, WonTech, Lumenis, Merz; Stock Shareholder: Advent Pharma |
Mercedes E. Gonzalez, MD, FAAD |
Honoraria & Speaker's Bureau: Pierre Fabre, Pfizer, EncoreDerm |
Ryan Hartwell, PhD |
Grant/Research Support: CIHR, AAF, WSBC, NSERC, JDRF, UBC, BCPFF; Stock Shareholder: BirchBioMed, Inc. |
Andrew Heyman, MD |
Nothing to Disclose |
Bruce E. Katz, MD |
Consultant: BTL; Grant/Research Support: Cynosure, Allergan; Honoraria: Merz, Galderma; Speaker's Bureau: Alma |
Mark D. Kaufmann, MD |
Stock Options for Modernizing Medicine, Inc. |
Jonette E. Keri, MD, PhD |
Consultant: Hoffman, LaRoche |
Leon Kircik, MD |
Abbott Laboratories: Speaker/Honoraria; Aclaris: Advisory Board; Acambis: Investigator; Allergan: Investigator, Advisory Board, Speaker, Consultant; Almirall: Consultant, Advisory Board; Amgen: Consultant, Investigator, Speaker; Anacor Pharmaceuticals: Investigator, Consultant, Advisory Board; Assos Pharma: Apeaker; Astellas Pharma: Investigator, Speaker; Asubio: Investigator; Berlex Laboratories (Bayer HealthCare Pharmaceuticals): Investigator; Biogen-Idec: Advisory Board; Biolife: Investigator; Biopelle: Investigator; Boehringer-Ingleheim: Investigator; Breckinridge Pharma: Investigator: Colbar: Consultant, Advisory Board; Celgene: Investigator, Advisory Board; Celgene: Investigator, Advisory Board; Centocor, Inc.: Investigator; Cellceutix: Investigator; Cipher: Consultant, Spaker, Advisory Board; Coherus: Investigator; CollaGenex: Investigator, Consultant, Speaker; Combinatrix: Investigator; Connetics Corporation: Investigator, Consultant, Speaker; Coria: Investigator; Dermavant: Investigator; Dermira: Investigator; Dermik Laboratories: Speaker; Dow Pharmacutical Sciences, Inc.: Investigator; Dusa: Investigator; Embil Pharmaceuticals: Speaker; Eli Lilly: Investigator; EOS: Advisory Board; Exeltis: Advisory Board, Consultant, Speaker, Investigator; Ferndale Laboratories: Advisory Board, Investigator; Galderma: Consultant, Speaker, Advisory Board, Investigator; Genentech: Advisory Board, Speaker, Investigator, Consultant; GlaxoSmithKline: Investigator; Health Point, LTD: Investigator; Idera: Investigator: Intendis: Advisory Board, Consultant, Investigator; Innocutis: Speaker, Advisory Board; Innovail; Speaker; Isdin: Advisory Board, Consultant; Johnson & Johnson: Consultant, Investigator, Advisory Board, Speaker, Stockholder; Laboratory Skin Care Inc.: Consultant; Leo: Investigator, Consultant, Speaker; L'Oreal: Investigator, Speaker; 3M: Speaker Investigator; maruho: Investigator; Medical International Technologies: Consultant; Merck: Consultant, Investigator; Medicis Pharmaceutical Corp.: Investigator; Merz: Consultant; Nano Bio: Advisory Board, Investigator; Noven Pharmaceuticals: Investigator; Nucryst Pharmaceuticals Corp: Investigator; Obagi: Investigator; Onset: Investigator, Speaker; OrthoNeutrogena: Speaker, Investigator, Advisory Board, Consultant; Promius: Investigator, Consultant, Advisory Board; PediaPharma: Speaker; QLT, Inc.: Investigator; PharmaDerm: Investigator, Speaker; Pfizer: Investigator; PuraCap: Consultant; Quinnova: Investigator, Advisory Board; Quatrix: Investigator; Serono (Merck Serono International SA): Speaker; SkinMedica, Inc.: Consultant, Investigator, Advisory Board, Speaker; Stiefel Laboratories, Inc.: Speaker, Investigator, Advisory Board, Consultant; Sun Pharma: Consultant, Advisory Board, Speaker, Investigator; Taro: Consultant/Speaker; TolerRx: Investigator; Triax: Speaker; UCB: Investigator, Consultant, Speaker; Valeant Pharmaceuticals Intl: Advisory Board, Investigator, Consultant; Valeant Pharmaceuticals Intl: Speaker; Warner-Chilcott: Advisory Board, Speaker, Investigator; XenoPort: Investigator; ZAGE: Consultant |
Robert Kirsner, MD |
Nothing to Disclose |
Mark G. Lebwohl, MD |
Research/Grant Support: Abbvie, Boehringer Ingelheim, Celgene, Eli Lilly, Incyte, Janssen/Johnson & Johnson, Leo Pharmaceuticals, Medimmune/Astra Zeneca, Novartis, Pfizer, Sciderm, Valeant, ViDac. Consultant: Allergan, Aqua, Dr. Reddy's Laboratories |
Henry W. Lim, MD |
Grant/Research Support (to the institution): Estee Lauder, Ferndale, Allergan, Incyte |
Z. Paul Lorenc, MD, FACS |
Consultant: Merz, Allergan, Galderma, Sinclair |
Stephen H. Mandy, MD |
Consultant: Proctor & Gamble, Almiral; Speaker's Bureau: Sinclair Pharma |
Gary D. Monheit, MD |
Consultant: Allergan, Revance, Galderma, Merz, Suneva; Grant/Research Support: Galderma, Teoxane, Allergan, Suneva, CROMA, Alphaeon, Sienna Pharmaceuticals |
Mark S. Nestor, MD, PhD |
Aclaris: Advisory Board/Honoraria; Actavis: Investigator/Grants; Aerolase: Advisory Board/Honoraria; Allergan: Investigator/Grants; Almirall: Advisory Board, Consultant/Honoraria; Annacor Pharmaceuticals: Investigator/Grants; Avita: Advisory Board/Honoraria; Bayer Healthcare: Advisory Board, Consultant/Honoraria; Brickell Biotech: Investigator/Grant; Castle Biosciences: Advisory Board/Honoraria; Cosmederm Biosciences: Investigator/Grant; CROMA Pharma GmbH: Investigator, Consultant/Grants/Honoraria; Cynova Laboratories: Investigator/Grant; DUSA Pharmaceuticals: Investigator/Grant; Demira: Investigator/Grant; Erchonia Corporation: Advisory Board/Honoraria; Evolus, Inc.: Investigator/Grants; Exeltis USA Dermatology: Investigator/Grants; Ferndale Laboratories: Advisory Board, Consultant, Investigator/Honoraria/Grants; Galderma Laboratories: Consultant, Investigator/Honoraria/Grants; IFC, S.A.: Investigator, Speaker/Grants/Honoraria; IntraDerm: Advisory Board/Honoraria; Johnson & Johnson: Advisory Board, Investigator, Consultant/Honoraria/Grants; La Lumiere, LLC: Advisory Board, Investigator, Consultant/Honoraria/Grants; LEO Pharma: Advisory Board, Investigator/Honoraria/Grants; Sensus Healthcare: Advisory Board, Consultant/Honoraria; Sinclair Pharma: Advisory Board, Investigator, Consultant/Honoraria/Grants; SkinFix: Advisory Board/Honoraria; Smith & Nephew: Advisory Board/Honoraria; Stratapharma: Advisory Board/Honoraria; Strathspey Crown: Stockholder; Thermi: Advisory Board, Speaker, Consultant/Honoraria |
Michael L. Nestor, ISD |
Nothing to Disclose |
Anna Nichols, MD, PhD |
Nothing to Disclose |
Gabriel Nistor, MD |
Stock Shareholder: AIVITA Biomedical, Inc. |
Suzanne Olbricht, MD |
Nothing to Disclose |
Margaret C. Oliviero, MSN, ARNP-C |
Consultant: 3 Gen, DermaSensor, Caliber ID, Heine, Canfield, FotoFinder |
David M. Pariser, MD, FAAD, FACP |
Consultant/Honoraria: Bickel Biotechnology, Biofrontera AG, Celgene Corporation, Dermira, DUSA Pharmacuticals, Inc. LEO Pharma, US, Novartis Pharmaceuticals Corp., Pfizer Inc., Promius Pharmaceuticals, Regeneron, Sanofi, TheraVida, Valeant Pharmacuticals International; Principal Investigator/Grants/Research Funding: LEO Pharma, US, Abbott Laboratories, Amgen, Bickel Biotechnology, Celgene Corporation, Dermavant Sciences, Eli Lilly and Company, LEO Pharma, US, Merck & Co., Inc., Novartis Pharmaceuticals Corp., Novo Nordisk A/S, Ortho Dermatologics, Peplin Inc., Pfizer Inc., Photocure ASA, Promius Pharmaceuticals, Regeneron, Stiefel a GSK company, Valeant Pharmaceuticals International; Advisory Board/Honoraria: Pfizer, Inc. |
Jason N. Pozner, MD, FACS |
Consultant: Cytrellis; Honoraria: Sciton, Lutronic, InMode; Speaker's Bureau: Sciton, InMode, Lutronic, Jeisys, Cynosure; Stock Shareholder: Sciton, Cytrellis, Revance, Therapeutics MD, RealSelf |
Harold S. Rabinovitz, MD |
Consultant: 3 Gen, Canfield, Caliber ID, FotoFinder, MoleScope, DermaSensor |
Darrell S. Rigel, MD |
Consultant: Aclaris Therapeutics, Inc.; Advisory Board: Beirsdorf, Inc., LEO Pharma US, Novartis, Pierre Fabre, Valeant; Principal Investigator: Johnson & Johnson, Neutrogena; Board of Directors: Foamix |
Theodore Rosen, MD |
Nothing to Disclose |
Frank Rosengaus, MD |
Nothing to Disclose |
William I. Roth, MD |
Consultant, Honoraria: Sensus Healthcare |
Neil S. Sadick, MD |
Almirall: Consultant, Honoraria; Galderma USA: Consultant, Fees; Slender Medical Ltd.: Advisory Board, Stock Options; Vascular Insights, LLC: Stockholder, Stock Options; Venus Concept: Consultant, Stock Options; Actavis: Principal Investigator, Grant/Research Funding; Allergan, Inc.: Consultant, Honoraria; Anacor Pharmaceuticals: Principal Investigator, Grants/Research Funding; Auxilium Pharmaceuticals, Inc.: Consultant, Honoraria; Bayer: Principal Investigator, Grants/Research Funding; Biorasi, LLC: Principal Investigator, Grants/Research Funding; BTG PLC: Consultant, Honoraria; Carma Laboratories, Inc.: Other, Honoraria; Cassiopea SpA: Principal Investigator, Grants/Research Funding; Celgene Corporation: Speaker, Honoraria, Principal Investigator, Grants/Research; Cutera, Inc.: Speaker, Honoraria; Cynosure, Inc.: Principal Investigator, Grants/Research, Consultant, Honoraria; DUSA Pharmaceuticals, Inc.: Principal Investigator, Grants/Research Funding; Eclipse Medical: Honoraria; Eli Lilly and Company: Principal Investigator, Grants/Research Funding; Endo International plc: Principal Investigator, Grants/Research Funding, Consultant, Honoraria; EndyMed Medical Inc.: Speaker, Honoraria; Eternogen: Consultant, Stock Options; Ferndale Laboratories, Inc.: Consultant, Honoraria; Galderma Laboratories, LP: Advisory Board, Honoraria; Galderma USA: Principal Investigator, Grants/Research Funding; Gerson Lehrman Group: Consultant, Honoraria; Hydropeptide, Inc.: Principal Investigator, Grants/Research Support; Merz Aesthetics: Advisory Board, Honoraria, Consultant; Neostrata: Principal INvestigator, Grant/Research Funding; Novartis: Principal Investigator, Grant/Research Funding; Nutraceutical Wellness, LLC: Principal Investigator, Grants/Research Support; Palomar Medical Technologies: Principal Investigaor, Grants/Research Funding; Prescriber's Choice: Honoraria; Regeneron: Principal Investigator, Grants/Research Funding; Roche Laboratories: Principal Investigator, Grants/Research Funding; Samumed, LLC: Principal Investigator, Grants/Research Funding; Solta Medical: Speaker, Honoraria; Storz Medical AG: Speaker, Honoraria; Suneva Medical Inc.: Advisory Board, Consultant, Honoraria; Valeant Pharmaceuticals International: Consultant, Principal Investigator, Grant/Research Funding, Honoraria; Vanda Pharmaceuticals Inc.: Principal Investigator, Grant/Research Funding; Venus Concept: Speaker, Honoraria |
Julie Santos, PA-C |
Nothing to Disclose |
Michael Sardano, JD |
Stock Shareholder: Sensus Healthcare, Inc.; Other/Royalty/Salary: Sensus Healthcare, Inc. |
Lawrence A. Schachner, MD |
Investigator: Astellas, Ferndale Labs, Novartis, Organogenesis, Inc., Stiefel Laboratories, Berg labs, Sciton, Medimetriks; Consultant: Beiersdorf, Lexington, TopMD, Medimetriks, Brickell |
Sahar Swidan, PharmD, BCPS, FAARFM, ABAAHP |
Honoraria: A4M, Amgen; Speaker's Bureau: A4M, Amgen |
Ken Tomecki, MD |
Nothing to Disclose |
Darlene Tomlinson, MBA, MHL |
Nothing to Disclose |
Antonella Tosti, MD |
Consultant: P&G, DS Laboratories; Other/Royalty: Springer Verlag, CRC Press, Karger |
David L. Wagener, MBA, CPA |
Stock Shareholder: Advanced Dermatology Management, Inc.; CEO: Skin & Cancer Associates |
Jill S. Waibel, MD |
Aquavit Pharmaceuticals - Clinical Trial, Stock Options; Cytrellis Biosystems - Clinical Trial ; Loreal - Speaker
Lumenis - Clinical Trial; Lutronic - Clinical Trial; Medisca - Clinical Trial; Norske - Clinical Trial; RegenX - Clinical Trial; Sciton - Advisory Board; Sebacia - Clinical Trial, Advisory Board; Syneron/Candela - Speaker, Consultant, Clinical Trial; Michaelson Diagnostics - Clinical Trial, Equipment; Strata Skin Sciences - Clinical Work; Dominion Aesthetics - Advisory Board |
Susan H. Weinkle, MD |
Consultant: Allergan/Galderma; Grant/Research Support: Revance, Alphaeon, Teoxane; Honoraria: Revance/Sinclair; Speaker’s Bureau: Sinclair; Stock Shareholder: Dermvance |
Cheryl Whitman |
Nothing to Disclose |
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Planner or Manager |
Reported Financial Relationship |
Ashley Marostica, RN, MSN |
Nothing to disclose |
Lindsay Borvansky |
Nothing to disclose |
Andrea Funk |
Nothing to disclose |
Liddy Knight |
Nothing to disclose |
Tiffany Blake |
Nothing to disclose |
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Tarsus Cardio, dba South Beach Symposium do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
System Requirements
PC
Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v5.5 or greater), Firefox, or Chrome |
MAC
MAC OS 10.2.8
Flash Player Plugin (v7.0.1.9 or greater)
Safari, or Chrome
Internet Explorer is not supported on the Macintosh. |
|
